Left Menu
Development News Edition

Biomaterials Market expected to reach USD 207 billion by 2024: Report

PR Newswire | Chicago | Updated: 14-06-2019 16:25 IST | Created: 14-06-2019 16:14 IST
Biomaterials Market expected to reach USD 207 billion by 2024: Report

According to the new market research report "Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024", published by MarketsandMarket, the Biomaterials Market is projected to grow at a CAGR of 14.5% during the forecast period, to reach USD 207 billion by 2024 from USD 105 billion in 2019.

Factors such as the increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidence of cardiovascular diseases, and raising awareness and research on regenerative medicine are driving the growth of the Biomaterials Market during the forecast period.

Metallic biomaterials accounted for the largest share of the Biomaterials Market in 2018

The metallic biomaterials segment accounted for the largest share of the Biomaterials Market, by type, in 2018. This is primarily attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopaedic applications. It is expected that the rise in geriatric population globally will increase the demand for these devices, as age increases susceptibility to orthopaedic, dental, ophthalmological, neurological, and cardiovascular disorders. In line with this, according to the American Joint Replacement Registry (AJRR), 860,080 hip and knee replacement procedures were performed in the US in 2017. This number is expected to reach 3.48 million procedures per year by 2030.

Cardiovascular applications segment accounted for the largest share of the Biomaterials Market in 2018

The cardiovascular applications segment accounted for the largest share of the Biomaterials Market, by application, in 2018. This is primarily due to the increasing prevalence of cardiovascular diseases, rising geriatric population, growing number of angiography procedures, and the increasing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators. For instance, according to the World Health Organization (WHO), 17.9 million people die each year from CVDs, which is an estimated 31% of all deaths worldwide. This figure is expected to grow to more than 23.6 million by 2030. Additionally, a number of diagnostic and therapeutic devices have been developed for cardiac applications. These devices include catheters, guidewires, sensors, pacemakers, implantable cardioverter defibrillators, vascular grafts, heart valves, and stents. Biomaterials are used for the manufacturing of these devices.

Asia Pacific region to register the highest growth in the Biomaterials Market during the forecast period

In 2018, North America accounted for the largest share of the Biomaterials Market, followed by Europe. Increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases are the factors propelling the growth of the Biomaterials Market in this region.

The Asia Pacific region is projected to register the highest growth rate in the Biomaterials Market during the forecast period, primarily due to the rising geriatric population in China and India, Japan's growing healthcare industry, and the rising prevalence of cardiovascular diseases in India.

Prominent players in the Biomaterials Market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorStek Inc. (US), CeramTec (Germany), and GELITA AG(Germany).


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

Most adults infected with COVID-19 in South Africa are asymptomatic cases: official

Of all adults infected with COVID-19 in South Africa, 50 to 66 per cent are asymptomatic cases, with many infections going undetected, a health official has claimed. The coronavirus, which first emerged in Chinas Wuhan city, has claimed 3,8...

U.S. sets record for new COVID cases third day in a row at nearly 69,000

New cases of COVID-19 rose by nearly 69,000 across the United States on Friday, according to a Reuters tally, setting a record for the third consecutive day as Walt Disney Co. stuck to its plans to reopen its flagship theme park in hard-hit...

'A free man': Trump commutes longtime adviser Roger Stone's prison sentence

President Donald Trump on Friday commuted the sentence of his longtime friend and adviser Roger Stone, sparing him from prison after he was convicted of lying under oath to lawmakers investigating Russian interference in the 2016 U.S. elect...

U.S. sets record for new COVID cases third day in a row at 67,000

New cases of COVID-19 rose by 68,000 across the United States on Friday, according to a Reuters tally, setting a record for the third consecutive day as Walt Disney Co. stuck to its plans to reopen its flagship theme park in hard-hit Florid...

Give Feedback